Innervace’s $40 Million Series A Financing

Troutman Pepper advised Innervace on the deal.Innervace, a regenerative medicine company developing the first implantable biofabricated neural pathway to restore brain circuitry, announced its $40 million…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now